Targeted Antigens of CAR-T Cell Therapy Information
| Target General Information | |||||
|---|---|---|---|---|---|
| Target ID | T82277 | Target Info | |||
| Target Name | Cancer/testis antigen 1 (NY-ESO-1) | ||||
| Synonyms | LAGE2B; LAGE2A; LAGE2; LAGE-2; L antigen family member 2; ESO1; Cancer/testis antigen 6.1; CTAG1B; CTAG1; CTAG; CT6.1; Autoimmunogenic cancer/testis antigen NYESO1; Autoimmunogenic cancer/testis antigen NY-ESO-1 | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | CTAG1A | ||||
| UniProt ID | |||||
| Targeted Antigens of CAR-T Cell Therapy | |||||
| CAR T-Cell Therapy Drug(s) | Anti-NY-ESO-1 CAR-T cells | Drug Info | Phase 1/2 | Synovial sarcoma | [1] |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.